LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
9.29
-0.47 (-4.82%)
At close: Apr 28, 2026, 4:00 PM EDT
9.45
+0.16 (1.72%)
After-hours: Apr 28, 2026, 7:04 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $291.28 million as of April 28, 2026. Its market cap has decreased by -42.96% in one year.
Market Cap
291.28M
Enterprise Value
3.20M
1-Year Change
-42.96%
Ranking
Category
Stock Price
$9.29
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $291.28M, a decrease of -29.58%. That is a compound annual growth rate of -15.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 306.02M | -38.87% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 309.52M |
| Abeona Therapeutics | 306.60M |
| Compugen | 293.12M |
| Minerva Neurosciences | 288.26M |
| Editas Medicine | 284.81M |
| NovaBridge Biosciences | 283.34M |
| Zentalis Pharmaceuticals | 282.31M |
| AC Immune | 281.73M |